News
Zacks Investment Research on MSN2h
Vertex Gets EU Nod for New Cystic Fibrosis Drug AlyftrekVertex Pharmaceuticals VRTX announced that the European Commission has approved Alyftrek ...
Vertex Pharmaceuticals secured EU approval for ALYFTREK, a next-gen cystic fibrosis therapy boasting a better efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback